R.M. Davis Inc’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,365
Closed -$235K 249
2019
Q3
$235K Buy
+2,365
New +$225K 0.01% 220
2018
Q2
Sell
-2,501
Closed -$223K 237
2018
Q1
$223K Sell
2,501
-1,048
-30% -$101K 0.01% 215
2017
Q4
$370K Buy
3,549
+480
+16% +$54.2K 0.01% 177
2017
Q3
$448K Sell
3,069
-14
-0.5% -$1.91K 0.02% 158
2017
Q2
$400K Sell
3,083
-477
-13% -$58.4K 0.02% 167
2017
Q1
$443K Sell
3,560
-195
-5% -$23.3K 0.02% 156
2016
Q4
$435K Sell
3,755
-645
-15% -$71.8K 0.02% 163
2016
Q3
$460K Sell
4,400
-50
-1% -$5.41K 0.02% 153
2016
Q2
$439K Buy
4,450
+1,090
+32% +$113K 0.02% 155
2016
Q1
$336K Sell
3,360
-976
-23% -$100K 0.02% 161
2015
Q4
$519K Buy
4,336
+16
+0.4% +$1.85K 0.03% 143
2015
Q3
$467K Buy
4,320
+1,945
+82% +$241K 0.03% 151
2015
Q2
$275K Buy
2,375
+153
+7% +$17.5K 0.01% 170
2015
Q1
$256K Buy
2,222
+128
+6% +$15.3K 0.01% 171
2014
Q4
$234K Sell
2,094
-298
-12% -$31.4K 0.01% 173
2014
Q3
$227K Sell
2,392
-384
-14% -$34.7K 0.01% 179
2014
Q2
$238K Buy
+2,776
New +$211K 0.01% 172

Other funds holding CELG

R.M. Davis Inc's CELG Position: Q4 2019 in Review

R.M. Davis Inc sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,365 shares — an estimated $235K sold.

R.M. Davis Inc first reported a position in CELG in Q2 2014 and held it in 17 quarters. The position peaked at $519K in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • R.M. Davis Inc reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • R.M. Davis Inc sold 2,365 Celgene Corp shares in Q4 2019, an estimated $235K.
  • R.M. Davis Inc first reported a position in Celgene Corp in Q2 2014 and held it in 17 quarters.
  • R.M. Davis Inc's Celgene Corp position peaked at $519K in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on R.M. Davis Inc's 13F filing for Q4 2019, filed 23 Jan 2020.